LIXT Earnings LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–16 of 16
| Q1 2026 | 2026-03-31 | -0.18 | 2026-05-14 | 10-Q |
| FY 2025 | 2025-12-31 | -1.26 | 2026-03-31 | 10-K |
| Q3 2025 | 2025-09-30 | -0.92 | 2025-11-12 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.57 | 2025-08-07 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.29 | 2026-05-14 | 10-Q |
| FY 2025 | 2024-12-31 | -1.59 | 2026-03-31 | 10-K |
| Q3 2025 | 2024-09-30 | -1.32 | 2025-11-12 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.88 | 2025-08-07 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.43 | 2025-05-12 | 10-Q |
| FY 2024 | 2023-12-31 | -2.66 | 2025-03-24 | 10-K |
| Q3 2024 | 2023-09-30 | -2.25 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -1.82 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.82 | 2024-05-09 | 10-Q |
| FY 2023 | 2022-12-31 | -3.99 | 2024-03-19 | 10-K |
| Q3 2023 | 2022-09-30 | -3.01 | 2023-11-09 | 10-Q |
| Q2 2023 | 2022-06-30 | -2.14 | 2023-08-09 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.